EKF Diagnostics Holdings (EKF Diagnostics Holdings) Debt-to-Equity

: 0.06 (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

EKF Diagnostics Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $4.41 Mil. EKF Diagnostics Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.78 Mil. EKF Diagnostics Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $84.96 Mil. EKF Diagnostics Holdings's debt to equity for the quarter that ended in Dec. 2023 was 0.06.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for EKF Diagnostics Holdings's Debt-to-Equity or its related term are showing as below:

EKDHF' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.03 Max: 0.23
Current: 0.06

During the past 13 years, the highest Debt-to-Equity Ratio of EKF Diagnostics Holdings was 0.23. The lowest was 0.01. And the median was 0.03.

EKDHF's Debt-to-Equity is ranked better than
77% of 713 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs EKDHF: 0.06

EKF Diagnostics Holdings Debt-to-Equity Historical Data

The historical data trend for EKF Diagnostics Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EKF Diagnostics Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.02

0.03

0.02

0.06

EKF Diagnostics Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.03	0.02	0.02	0.01	0.06

Competitive Comparison

For the Medical Devices subindustry, EKF Diagnostics Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EKF Diagnostics Holdings Debt-to-Equity Distribution

For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where EKF Diagnostics Holdings's Debt-to-Equity falls into.

EKF Diagnostics Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

EKF Diagnostics Holdings's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.406	+	0.782)	/	84.958
	=	0.06

EKF Diagnostics Holdings's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.406	+	0.782)	/	84.958
	=	0.06

EKF Diagnostics Holdings (OTCPK:EKDHF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

EKF Diagnostics Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of EKF Diagnostics Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

EKF Diagnostics Holdings (EKF Diagnostics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » EKF Diagnostics Holdings PLC (OTCPK:EKDHF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

EKF.GB:UK EKF:UK

Address

19 Stanwell Road, Penarth, Avon House, Cardiff, GBR, CF64 2EZ

Website

https://www.ekfdiagnostics.com

EKF Diagnostics Holdings PLC is engaged in the field of medical diagnostics. The company's core business is point-of-care testing and manufacturing reagents for use in central laboratories. It caters to companies focused on areas such as diabetes, blood banking, and sports medicine. The company derives its income from its sales in the United States. Its other markets include Germany, Poland, and Russia.

EKF Diagnostics Holdings (EKF Diagnostics Holdings) Headlines

From GuruFocus

Full Year 2021 EKF Diagnostics Holdings PLC Earnings Call Transcript

By GuruFocus Research • 03-26-2024